Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Claudio Feliciani; A Mehta; M Beck; P Elliott; R Giugliani

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Claudio Feliciani, A Mehta, M Beck, P Elliott, R Giugliani

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	-
Number of pages	10
Journal	The Lancet
Publication status	Published - 2009
Externally published	Yes

Keywords

FOS
fabry

Cite this

@article{6015f7a1220b4e129e7f05b7c3502691,

title = "Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data",

keywords = "FOS, fabry, FOS, fabry",

author = "Claudio Feliciani and A Mehta and M Beck and P Elliott and R Giugliani",

year = "2009",

language = "English",

pages = "--",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Lancet Limited:42 Bedford Square, London WC1B 3SL United Kingdom:011 44 207 4364981, EMAIL: custserv@lancet.com, INTERNET: http://www.thelancet.com, Fax: 011 44 207 3236433",

}

TY - JOUR

T1 - Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

AU - Feliciani, Claudio

AU - Mehta, A

AU - Beck, M

AU - Elliott, P

AU - Giugliani, R

PY - 2009

Y1 - 2009

KW - FOS

KW - fabry

KW - FOS

KW - fabry

UR - http://hdl.handle.net/10807/29676

M3 - Article

SP - -

JO - The Lancet

JF - The Lancet

SN - 0140-6736

ER -

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Keywords

Other files and links

Cite this